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SUMMARY
Plasma cell survival and the consequent duration
of immunity vary widely with infection or vaccination.
Using fluorescent glucose analog uptake, we
defined multiple developmentally independent
mouse plasma cell populations with varying life-
spans. Long-lived plasma cells imported more fluo-
rescent glucose analog, expressed higher surface
levels of the amino acid transporter CD98, and had
more autophagosome mass than did short-lived
cells. Low amino acid concentrations triggered re-
ductions in both antibody secretion and mitochon-
drial respiration, especially by short-lived plasma
cells. To explain these observations, we found that
glutamine was used for both mitochondrial respira-
tion and anaplerotic reactions, yielding glutamate
and aspartate for antibody synthesis. Endoplasmic
reticulum (ER) stress responses, which link meta-
bolism to transcriptional outcomes, were similar
between long- and short-lived subsets. Accordingly,
population and single-cell transcriptional compari-
sons across mouse and human plasma cell
subsets revealed few consistent and conserved dif-
ferences. Thus, plasma cell antibody secretion and
lifespan are primarily defined by non-transcriptional
metabolic traits.
INTRODUCTION
Upon infection or vaccination, naive B cells become activated by
foreign antigens, and a subset of these cells differentiate into
antibody-secreting plasma cells. Once formed, plasma cells
secrete antibodies constitutively as long as they live (Manz
et al., 1998; Slifka et al., 1998). Because these antibodies pre-
exist subsequent exposures to pathogens, plasma cells have
the ability to provide sterilizing immunity and prevent re-infec-
tion. As a result, plasma cells and the antibodies they produce
are the primary determinants of humoral immunity following
vaccination (Zinkernagel and Hengartner, 2006). The transience
of plasma cell persistence and consequent antibody production
is the major reason for the loss of immunity against infectious
diseases such as malaria (Weiss et al., 2010; White et al.,
2015). Reciprocally, long-lived plasma cells pose a major prob-
lem in certain autoimmune disorders and are the cell of origin
in multiple myeloma (Winter et al., 2012). A mechanistic under-
standing of plasma cell survival may provide additional targets
for the above disorders.
In T cell-dependent reactions, an initial wave of extrafollicular
plasma cells tends to be relatively short-lived and produces
germline-encoded antibodies (Sze et al., 2000). These cells
form an early response to provide partial control of the infection
until plasma cells encoding higher affinity antibodies emerge
later from the germinal center reaction. As the germinal center
progresses, there is a concomitant increase in both the affinity
of the encoded antibodies as well as in the lifespans of the
selected plasma cells (Weisel et al., 2016). Yet germinal centers
are not required per se for the formation of long-lived plasma
cells. T cell-independent responses, which yield neither germinal
centers nor robust immunological memory, can also yield
plasma cells of extended lifespans, as well as a proliferative
subset of antibody-secreting cells that together maintain serum
antibodies long after immunization (Bortnick et al., 2012; Rey-
nolds et al., 2015; Savage et al., 2017). These and other data
demonstrate substantial functional heterogeneity in ontogeny
and lifespan within the plasma cell compartment (Amanna
et al., 2007), but the underlying molecular basis is unclear.
We reasoned that coupling specific metabolic and transcrip-
tional properties in conjunction with other markers would allow
for prospective separation of new plasma cell subsets with a
range of lifespans. This in turn would allow for an assessment
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of how metabolic, transcriptional, and endoplasmic reticulum
(ER) stress pathways integrate to regulate plasma cell lifespan
and antibody secretion. Using this strategy, we found a very
limited correlation between transcriptional changes, ER stress
responses, and plasma cell lifespan. Instead, nutrient uptake
and catabolism consistently distinguished plasma cell subsets
with differing lifespans and antibody secretion rates.
RESULTS
Prospective Separation of Developmentally Distinct
Plasma Cell Subsets with Varying Lifespans
We reasoned that prospectively separating plasma cells into
functionally distinct groups would provide a cellular foothold to
define pathways that regulate lifespan. Intracellular staining for
immunoglobulin k (Igk) demonstrated very high levels of anti-
bodies in almost all CD138high cells (Figure S1A). We further
separated polyclonal CD138+ plasma cells in the spleen and
bone marrow, formed in response to natural infections in the col-
ony, based on uptake of 2-(N-(7-nitrobenz-2-oxa-1,3-diazol-
4-yl)amino)-2-deoxyglucose (2NBDG), a fluorescent glucose
analog (Yoshioka et al., 1996), and expression of B220, which
marks relatively short-lived and/or proliferative and immature
cells (Chernova et al., 2014; Kallies et al., 2004). Using these
criteria, splenic plasma cells could be readily separated into
four distinct subsets (Figure S1B). Although all plasma cells
imported 2NBDG above background levels, for simplicity we
designate the subsets gated as in Figure S1B as either
2NBDG+ or 2NBDG. Bone marrow plasma cells were domi-
nated by the B2202NBDG+ subset, whereas the other subsets
were too rare to work with easily (Figure S1B). Therefore, the
B2202NBDG+ subset was specifically purified for all subse-
quent analyses of bone marrow plasma cells.
To quantify the half-lives of plasma cell subsets, we performed
pulse-chase experiments using bromodeoxyuridine (BrdU).
Mice were provided BrdU in the drinking water for 1 week, fol-
lowedby either 0, 1, or 2weeks ofwater without BrdU (Figure 1A).
Animals were then injected with 2NBDG and sacrificed 15 min
later. The splenic B220+2NBDG subset demonstrated the
shortest half-life of approximately 3–4 days, followed by the
B2202NBDG subset (4–6 days), B220+2NBDG+ cells
(5–18 days), B2202NBDG+ cells (8–12 days), and bone marrow
(BM) plasma cells, which showed no turnover during this limited
3-week experiment (Figure 1A). For B220+2NBDG+ and
B2202NBDG+ cells, the BrdU decay rates varied between
weeks 2 and 3. These data suggest additional heterogeneity
within these subsets, with a fraction of cells that either proliferate
or die rapidly, and another subset that persists more durably
without division. Thus, plasma cells that import high levels
of 2NBDG have longer half-lives than do their 2NBDG
counterparts.
Loss of BrdU retention during the chase period could have
been caused by death, proliferation, or differentiation to a
distinct plasma cell subset. To distinguish between these possi-
bilities, we first quantified antigen-specific plasma cell numbers
over time in each subset after immunization with alum-adju-
vanted 4-hydroxy-3-nitrophenylacetyl-ovalbumin (NP-OVA), a
T cell-dependent antigen. The initial NP-specific response at
1 week was dominated by the 2NBDG groups, with nearly
80% of antigen-specific plasma cells contained within
B220+2NBDG and B2202NBDG subsets (Figure 1B). Never-
theless, NP-specific cells could also clearly be found within the
B2202NBDG+ and B220+2NBDG+ subsets (Figure 1B), sug-
gesting the contemporaneous generation of each of these four
plasma cell populations. At these early time points, very few
NP-specific bone marrow plasma cells were found (data not
shown). Subsequent weeks revealed that NP-specific cells
were rapidly lost from the 2NBDG subsets, whereas after an
initial decay, antigen-specific cell numbers were relatively stable
in both 2NBDG+ subsets (Figure 1B). These data mirror the BrdU
pulse-chase experiments above and suggest that the major
portion of plasma cell turnover in each of these subsets is driven
by death. Moreover, the contemporaneous formation of multiple
plasma cell subsets argues against a strict developmental hier-
archy between these groups.
Initial efforts to determine whether plasma cell subsets can
interconvert failed because of poor cell recovery after adoptive
transfer. Therefore, as an alternative approach, we quantified
CD93 expression. CD93 is a marker of developmental maturity
and is itself required for long-term maintenance of plasma cells
(Chevrier et al., 2009). The percentage of CD93+ cells was some-
what lower in 2NBDG plasma cell subsets, but each subset dis-
played a substantial fraction of mature CD93+ cells (Figure 1C).
These data again suggest that each plasma cell subset defined
by B220 expression and 2NBDG uptake is formed and matures
independently of one another.
To further examine the developmental relationships between
plasma cell subsets, we performed immunoglobulin repertoire
sequencing of polyclonal populations. Within the immunoglob-
ulin G (IgG) isotypes, we observed very little overlap (<10% for
most comparisons) between B220+ and B220 subsets, both
within the spleen and bone marrow (Figures 1D and S1C). These
data are consistent with previous studies demonstrating differ-
ential light chain usage between B220+ and B220 subsets
(Chernova et al., 2014). IgM-expressing plasma cells showed
somewhat more overlap (15%–25%) between all subsets (Fig-
ures 1D and S1C). Although this may reflect somewhat more
interconversion across immunoglobulin M+ (IgM+) plasma cell
subsets, it seems likely that this overlap occurs because these
cells arise from precursor B-1 cells (Savage et al., 2017), which
have relatively restricted repertoires (Yang et al., 2015). Within
the B220+ or B220 subsets, we observed 15%–20% overlap
between CDR3 nucleotide sequences of 2NBDG+ and 2NBDG
cells (Figures 1D and S1C). Two of the most diverse subsets
were the B220+2NBDG IgG and the B220+2NBDG+ IgG groups
(Figure S1D). Despite their diversity, these two populations
showed themost overlap (25%) of all sets of comparisons (Fig-
ure 1D). Reciprocally, the bone marrow IgG group was among
the least diverse (Figure S1D), yet showed minimal overlap
with any other subset in the same animal (Figure 1D). Thus, it
does not appear that diversity per se artificially suppresses the
clonal overlap between two groups. These data suggest that
developmental interconversion might account for a minor
portion of ontogeny, but that themajority of plasma cell immuno-
globulin sequences in each subset are unique. We conclude that
fluorescent glucose uptake can be used to purify plasma cells of
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Figure 1. Glucose UptakeCorrelateswith Long
Half-Lives in Plasma Cell Subsets
(A)Mice were fed BrdU in the drinkingwater for 1week
and assessed for incorporation and retention at 0, 1,
and 2 weeks post-BrdU withdrawal. Half-lives of each
plasma cell population were calculated at weeks 1
and 2 of the chase period and are shown above each
dataset. Data are cumulative from two independent
experiments. Mean values ± SEM are shown.
(B) Mice were immunized with NP-OVA, and antigen-
specific plasma cells were assessed 1, 2, and 3weeks
thereafter. Example flow cytometric plots (left) and
quantification (right) are shown from CD138-enriched
cells and surface NP staining. Data are cumulative
from two independent experiments. Mean values ±
SEM are shown, as are the fold decreases relative to
the previous time point.
(C) Representative CD93 staining of each plasma cell
subset is shown to the left. Cumulative data from two
independent experiments are shown to the right. Each
data point represents cells from one mouse, and
subsets from the samemouse are connected by lines.
*p < 0.05, by paired one-way ANOVA with post hoc
Tukey’s multiple comparisons test.
(D) Heatmap showing percent clonal overlap between
CDR3 nucleotide sequences of plasma cell pop-
ulations. Plasma cell populations were sorted and
immunoglobulin heavy chain VDJ sequences were
amplified with common V region primers and either
Cm- or pan-Cg-specific primers. Heatmap is derived
from one individual mouse out of a total of three
analyzed. Data from the remaining mice are shown in
Figure S1.
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differing lifespans and to help define other pathways that regu-
late survival, independently of developmental relationships.
Amino Acids Are Limiting for Plasma Cell Respiration
and Antibody Secretion
Imported glucose is used both to glycosylate antibodies and to
provide spare respiratory capacity, thereby allowing long-lived
plasma cells to survive (Lam et al., 2016). This suggests a model
in which the very nutrients used to synthesize immunoglobulins
are also used to promote survival and energy metabolism in anti-
body-secreting cells (Lam and Bhattacharya, 2018). To extend
upon this model, we assessed plasma cell metabolism of amino
acids. We first assessed CD98/SLC3A2 expression, a common
subunit for many amino acid transporters (Mastroberardino
et al., 1998), and thus a marker of amino acid availability. CD98
expression is controlled by the transcription factor BLIMP1 and
thus is very high in plasma cells (Shi et al., 2015; Tellier et al.,
2016). CD98 deficiency leads to severe antibody defects, mostly
as a function of its adhesion domain being required for activated
B cell proliferation (Cantor et al., 2009), but amino acid transport
is likely to be essential at the plasma cell stage (Tellier et al.,
2016). 2NBDG plasma cells expressed modestly but consis-
tently lower cell surface levels of CD98 than did 2NBDG+ cells
(Figure 2A). This difference was not simply a function of cell
size, because B220+2NBDG, B2202NBDG+, and bone
marrow plasma cells all showed comparable forward scatter
measurements (Figure S2). Amino acids can also be derived
intrinsically by autophagy as cellular components are recycled.
Although autophagy is normally inversely correlated with extra-
cellular amino acid uptake, 2NBDG+ plasma cells modestly but
consistently stained more brightly with a dye that marks auto-
phagosomes (An et al., 2017) than did 2NBDG cells (Figure 2B).
These autophagy data are consistent with previous human
plasma cell studies (Halliley et al., 2015).
The changes in CD98 expression and autophagy dye staining
were subtle and of unclear functional significance. Moreover,
many amino acids are transported independently of CD98 and
would not be accounted for in these analyses. Therefore, we
sought to perform functional assays to test the sensitivity of
plasma cell subsets to extracellular amino acid concentrations.
Plasma cells that are genetically deficient in autophagy display
reduced levels of ATP (Pengo et al., 2013), suggesting that
2NBDG cells may also display reduced energy metabolism
when amino acids are limiting. Indeed, a retrospective analysis
of our previous work revealed that primary plasma cells assayed
under physiological amino acid concentrations have lower levels
of respiration than cells in standard RPMI media (Figure 2C),
which have supraphysiological concentrations of amino acids
(Lam et al., 2016). This difference was most pronounced in
2NBDG plasma cells (Figure 2C). To determine whether amino
acid availability also limits antibody secretion by plasma cells,
we cultured each subset with physiological or supra-physiolog-
ical concentrations of amino acids in otherwise identical media.
A clear association was observed between elevated amino acid
Figure 2. Amino Acids Are Limiting for
Plasma Cell Respiration and Antibody
Secretion
(A) CD98 expression in plasma cell populations is
shown as a representative plot (left) and quantified
as mean fluorescence intensity (MFI) values to the
right. Data are cumulative from two independent
experiments, and each point represents cells from
an individual mouse. Mean values ± SEM are
shown. *p < 0.05, **p < 0.005, ***p < 0.0005 by one-
way ANOVA with post hoc Tukey’s multiple com-
parisons test.
(B) Autophagosome staining of plasma cell pop-
ulations. Representative graph of autophagy blue
staining (left) and quantification of MFI values cu-
mulative from two experiments (right). Each data
point represents cells from an individual mouse,
and subsets from the same animal are connected
by lines. *p < 0.05, **p < 0.005 by paired one-way
ANOVA with post hoc Tukey’s multiple compari-
sons test.
(C) Oxygen consumption rates of 2NBDG+ or
2NBDG cells cultured either in physiological
media or media with supraphysiological concen-
tration of amino acids. Data from the same
experiment are connected by lines. *p < 0.05 by
Student’s two-tailed paired t test.
(D) Antibody secretion analysis of plasma cell
populations cultured for 24 hr either in physiolog-
ical media or media with supraphysiological con-
centrations of amino acids. *p < 0.05, ***p < 0.0005
by two-way ANOVA with post hoc Sidak’s multiple
comparisons test.
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concentrations and antibody secretion rates in most subsets
(Figure 2D). 2NBDG+ plasma cells continued to secrete more an-
tibodies than did 2NBDG cells under both low- and high-amino
acid conditions (Figure 2D). This enhanced secretion by 2NBDG+
cells occurred despite apparently elevated levels of autophagy
(Figure 2C), which is known to limit immunoglobulin production
(Pengo et al., 2013).
Previous studies on myeloma cell lines have demonstrated
that glutamine catabolism is essential for energy metabolism,
amino acid production, and survival (Garcia-Manteiga et al.,
2011; Thompson et al., 2017). 13C-glutamine tracing experi-
ments on primary human long-lived plasma cells demonstrated
robust contributions to glutamate and aspartate synthesis, and
labeled carbons were readily observed in the tricarboxylic acid
(TCA) cycle intermediatesmalate and fumarate (Figure 3A). How-
ever, no label was detected in citrate or aconitate (Figure 3A).
Figure 3. Glutamine Catabolism Links
Mitochondrial Function to Amino Acid
Biosynthesis
(A) Liquid chromatography-mass spectrometry
analysis of 13C enrichment in human bone marrow
plasma cell intermediary metabolites. Plasma cells
were cultured for 18 hr with uniformly labeled
13C-glutamine-containing media. Isotopologue
distributions were corrected for natural abundance
and isotope impurity. Mean values of four biolog-
ical replicates ± SEM are shown.
(B) Schematic of glutamine contribution to the TCA
cycle in plasma cells. Red indicates intermediates
in which glutamine-derived carbons are found.
Thus, glutamine is used for anaplerotic
reactions to generate glutamate and
aspartate (Figure 3B). By contributing to
succinate oxidation, glutamine also pro-
vides electrons for respiration (Lehninger
et al., 2013). Although glutamine alone is
unlikely to account for the entirety of the
link, these data confirm that the same nu-
trients used to maintain mitochondrial
function are also used to generate the
amino acid building blocks for immuno-
globulin synthesis. It is also likely that
amino acid availability promotes antibody
secretion through other mechanisms
aside from immunoglobulin translation
(Zacharogianni et al., 2011).
ER Stress Responses Are Similar
across Plasma Cell Subsets
To define how metabolic modules inte-
grate with transcriptional outputs, we first
focused on ER stress responses, which
can link these pathways. 13C tracing ex-
periments in human bone marrow plasma
cells revealed that a substantial portion
of uridine diphosphate N-acetylglucos-
amine (UDP-GlcNac), a precursor to
glycosylation sugars, is generated by import of extracellular
glucose (Figure S3). Reductions in protein glycosylation and
subsequent misfolding of antibodies trigger ER stress responses
in plasma cells (Hickman et al., 1977). Given that short-lived
plasma cells import relatively little glucose, we reasoned that
they may underglycosylate proteins and antibodies, and thus
be subject to more ER stress than are their long-lived counter-
parts. ER stress responses are necessary for high levels of anti-
body secretion, but they can also limit the lifespan of plasma
cells (Auner et al., 2010; Reimold et al., 2001).
Splicing of XBP1 toXBP1sby IRE1a, cleavage of ATF6a into an
active transcription factor, and phosphorylation of eIF2a by eu-
karyotic translation initiation factor 2 alpha kinase 3/protein
kinase R-like endoplasmic reticulum kinase (EIF2AK3/PERK)
represent the three armsof the ERstress response (Ron andWal-
ter, 2007). Expression of ATF6a targets, such as HSPA5, varied
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slightly across subsets, with the lowest levels in B220+2NBDG
and bonemarrow plasma cells (Figure 4A), but XBP1s and down-
stream targets such as EDEM1 were similarly expressed by all
groups (Figure 4A). This analysis revealed no significant changes
in ER stress responses that correlated with 2NBDG uptake and,
as a result, with lifespan (Figure 4A). Previous studies have sug-
gested that caspase-12 activation might promote ER stress-
dependent apoptosis in short-lived plasma cells (Auner et al.,
2010). Yet cleavage of a caspase-12 substratewas similar across
all plasma cell subsets (Figure 4B). These data demonstrate that
the XBP1s andATF6a-dependent ER stress pathways are similar
between short- and long-lived plasma cells. We next examined
the remaining ER stress pathway, mediated by phosphorylation
of eIF2a. Although previous studies using in vitro cultures found
minimal phosphorylation of eIF2a (Ma et al., 2010), we observed
clear activation of this pathway in all plasma cell subsets ex vivo
(Figure 4C). B220+ plasma cells displayed slightly elevated levels
of p-eIF2a relative to their B220 counterparts (Figure 4C). How-
ever, no changes were observed in p-eIF2a as a function of
2NBDG uptake (Figure 4C).
We considered the possibility that short-lived plasma cells
succumb to apoptosis because of a relative inability, rather
than an excessive propensity, to mount ER stress responses.
Neither XBP1 nor ATF6a are required for plasma cell survival
(Aragon et al., 2012; Taubenheim et al., 2012), yet the necessity
of eIF2a phosphorylation in plasma cells in vivo remains unre-
solved (Gass et al., 2008; Mielke et al., 2011; Scheuner et al.,
2001). Therefore, we first defined the relevant kinases involved
in eIF2a phosphorylation in plasma cells. We isolated human
bone marrow plasma cells, due to their abundance, and exam-
ined the effects of pharmacological inhibitors of each of the
kinases involved in eIF2a phosphorylation (Ron and Walter,
2007). Inhibition of PERK, but not of general control nondere-
pressible 2 (GCN2), protein kinase R (PKR), or Heme-regulated
inhibitor (HRI), completely eliminated p-eIF2a (Figure 4D).
Thus, PERK is solely responsible for eIF2a phosphorylation in
plasma cells.
Consistent with previous in vitro-generated plasma cells in
lipopolysaccharide (LPS) cultures (Gass et al., 2008), we
observed no effect of PERK inhibition on survival or antibody
Figure 4. ER Stress Responses Are Similar
across Plasma Cell Subsets
(A) qRT-PCR analysis of ER stress response genes
in plasma cell subsets. Data are cumulative from
two individual experiments, each with three bio-
logical replicates of each plasma cell subset. Data
are normalized to expression of HPRT. *p < 0.05,
**p < 0.005, ***p < 0.0005, ****p < 0.00005 by two-
way ANOVA with post hoc Sidak’s multiple com-
parisons test.
(B) Caspase-12 activation in plasma cell pop-
ulations. Plasma cell populations were sorted and
labeled for 1 hr with the fluorescent caspase-12
inhibitor ATAD-FMK. Representative plots (left)
and quantification (right) are shown, with each
data point representing cells from an individual
mouse. Mean values ± SEM are shown. No sig-
nificant differences were observed using one-way
ANOVA.
(C) Flow cytometric representative plots (left) and
quantification (right) of p-eIF2amean fluorescence
intensities (MFIs) in plasma cell subsets. *p < 0.05
by one-way ANOVA with post hoc Tukey’s multi-
ple comparisons test.
(D) Human bonemarrow plasma cells were treated
with inhibitors to PERK (4 nM GSK2606414),
GCN2 (500 mM SP600125 or indirubin-30-mon-
oxime), HRI (50 mM hemin), or PKR (100 mM imid-
azole-oxindole C16) for 1 hr and analyzed for
intracellular p-eIF2a. Plots of p-eIF2a represen-
tative of two independent experiments are shown.
(E) Schematic representation of mixed bone
marrow chimera experiment to assess plasma cell
population dependence on PERK (left). CD45.2+
chimerism values are shown (right) and are
cumulative from two experiments. Each symbol
represents a distinct mouse. ****p < 0.00005 by
two-way ANOVA with post hoc Sidak’s multiple
comparisons test.
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secretion ex vivo (Figures S4A and S4B). To test the importance
of PERK for plasma cell survival in vivo, we utilized conditional
Perkfl/fl mice crossed to transgenic animals ubiquitously ex-
pressing tamoxifen-inducible CreERT2 (Guthrie et al., 2016).
Equal numbers of CD45.2 Perkfl/fl or Perkfl/fl CAGG-CreERT2
bone marrow cells were mixed with wild-type competitor
CD45.1 bone marrow cells and transplanted into irradiated
CD45.1 recipients. At 8 weeks post-transplant, mice were given
tamoxifen-containing chow for 2 weeks. CD45.2 chimerism was
then measured of B lymphocytes and plasma cells formed in
response to natural infections in the colony. Chimerism of
splenic B cells was similar irrespective of Perk genotype (Fig-
ure 4E). Within the plasma cell subsets, we observed a small
but consistent reduction in PERK-deficient B220+2NBDG
and B220+2NBDG+ plasma cells relative to controls (Figures
4E and S4C). In contrast, no statistically significant reduc-
tions were observed in PERK-deficient B2202NBDG or
Figure 5. Plasma Cells with Diminished
Glucose Uptake Maintain Translation Rates
but Secrete Relatively Few Antibodies
(A) Representative plots (left) and quantification of
mean fluorescence intensity (MFI) values (right) of
total surface and intracellular Igk staining of splenic
and bonemarrowCD138+ plasma cells. Each point
represents an individual mouse, and data are cu-
mulative of three independent experiments. Mean
values ± SEM are overlaid. No significant differ-
ences were observed by one-way ANOVA.
(B) Mice were injected with puromycin and
2NBDG, and sacrificed 15 min later. Representa-
tive puromycin staining (left) and quantification of
MFI values (right) of splenic and bone marrow
plasma cells are shown. Data are from one repre-
sentative experiment of three total. Each point
represents an individual mouse, and subsets from
the same mouse are linked by lines. No significant
differences were observed by paired one-way
ANOVA.
(C) Plasma cell populations were sorted and
cultured for 24 hr with or without protein translation
inhibitor cycloheximide. Representative total sur-
face and intracellular Igk staining (left) and quan-
tification (right) of splenic and bonemarrow plasma
cells. Each point represents an individual mouse,
and data are cumulative of two independent
experiments. Subsets from the same mouse are
linked by lines. *p < 0.05, ***p < 0.0005,
****p < 0.00005 by paired two-way ANOVA with
post hoc Sidak’s multiple comparisons test.
(D) Antibody secretion measured by ELISA after
overnight culture of plasma cell subsets from
spleen and bone marrow. Each point represents
a plasma cell subset from one individual mouse.
*p < 0.05, **p < 0.005 by one-way ANOVAwith post
hoc Tukey’s multiple comparisons test. Data are
cumulative from three independent experiments.
B2202NBDG+ plasma cells (Figure 4E).
Bone marrow plasma cell chimerism
was also similar between genotypes, but
we were unable to confirm efficient dele-
tion of Perk in these cells (Figure S4D). These data demonstrate
that PERK promotes either survival or formation of B220+ plasma
cells in vivo. However, this dependency on PERK is not corre-
lated with glucose uptake, and thus fails to explain inherent dif-
ferences in survival between plasma cell subsets.
ER stress in 2NBDG cells could potentially be mitigated by
reducing overall rates of protein and antibody production.
Indeed, examination of electron micrographs revealed no
consistent alterations in ER lumenal distension (Figures S5A
and S5B), a marker of misfolded protein accumulation (Oslowski
and Urano, 2011). Each plasma cell subset also displayed similar
total levels of Igk protein and mRNA (Figures 5A and S5C). To
test whether the rates of protein translation differ between cell
types, we employed in vivo ribopuromycylation in which puromy-
cin is incorporated into nascent polypeptides, leading to chain
termination (Seedhom et al., 2016). Mice were injected with pu-
romycin and 2NBDG, sacrificed 15 min later, and intracellular
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levels of puromycin were measured. All plasma cell subsets had
similar levels of puromycin labeling, and there was no correlation
between 2NBDG uptake and translation rates (Figure 5B).
Consistent with these findings, each subset displayed similar
levels of phosphorylated S6 (Figure S5D), a marker of mamma-
lian target of rapamycin (mTOR) activation, which promotes
translation and antibody synthesis in plasma cells (Jones et al.,
2016). Together, these data demonstrate that despite marked
differences in glucose uptake, no compensatory changes are
engaged in plasma cell subsets to modulate immunoglobulin
synthesis and protein translation.
Another mechanism that could mitigate stress responses is
protein degradation. To quantify the rates of antibody turnover,
we treated plasma cells with the protein translation inhibitor
cycloheximide for 24 hr and quantified intracellular levels of
Igk. Although Igk light chain itself is infrequently glycosylated, it
is degraded unless paired with properly folded and glycosylated
immunoglobulin heavy chain isotypes (Chillaro´n and Haas,
2000). As in Figure 5A, antibody levels were similar in all subsets
in the untreated control group (Figure 5C). Upon cycloheximide
treatment, however, both 2NBDG subsets showed a substan-
tial loss in Igk relative to their 2NBDG+ counterparts (Figure 5C).
The loss of antibodies in 2NBDG plasma cells after cyclohexi-
mide could be driven by degradation or by antibody secretion.
However, consistent with Figure 2D, 2NBDG cells secreted
substantially fewer antibodies than did their 2NBDG+ counter-
parts (Figure 5D). Thus, 2NBDG plasma cells degrade anti-
bodies more rapidly than do their 2NBDG+ counterparts, and
this may be a mechanism by which they avoid excessive ER
stress.
Transcriptional Profiles Are Similar between Plasma
Cell Subsets
Given that ER stress responses were similar between short- and
long-lived plasma cell subsets, we examined the global tran-
scriptional profiles of these subsets in an unbiased way to iden-
tify other genes that are correlated with glucose uptake and life-
span. After excluding immunoglobulin genes, RNA-sequencing
(RNA-seq) comparisons of short-lived B2202NBDG and
long-lived B2202NBDG+ plasma cells revealed remarkably
similar transcriptional profiles. A total of 29 genes, representing
less than 0.2% of the total transcriptome, showed a statistically
significant increase in the 2NBDG+ subset (>2-fold change in
expression, adjusted p value < 0.05; Figure 6A). Within the
B220+ plasma cells, 341 genes were differentially expressed in
2NBDG+ cells relative to their 2NBDG counterparts (Figure 6A,
middle panel). A comparison of long-lived bone marrow
B2202NBDG+ plasma cells with short-lived splenic
B2202NBDG plasma cells revealed more robust changes,
with 900 differentially expressed transcripts (Figure 6A, right
panel). Pro-apoptotic Bcl-2-like protein 11 (BIM) was modestly
decreased in B2202NBDG cells relative to their 2NBDG+
counterparts, but in none of these comparisons did we observe
differential expression of a number of other known plasma cell
survival factors, such as myeloid leukemia cell differentiation
protein 1 (MCL1), B cell maturation antigen (BCMA), CD28, or
interleukin-6R (IL-6R) (Minges Wols et al., 2002; O’Connor
et al., 2004; Peperzak et al., 2013; Rozanski et al., 2011).
To define a common transcriptional signature used by
2NBDG+ cells, we performed intersection analysis. Only 15
genes were coordinately upregulated and 15 genes downregu-
lated in B2202NBDG+ or B220+2NBDG+ splenic plasma cells
relative to their 2NBDG counterparts (Figure 6B). We next
compared these 30 genes with transcripts differentially ex-
pressed in human long- versus short-lived plasma cells. We
observed 66 genes elevated, including pro-survival CD28, and
20 genes downregulated in CD19 human long-lived plasma
cells relative to their CD19+ short-lived counterparts (Figure 6C).
Only one gene, Tmem176b, demonstrated overlap between
genes consistently elevated in mouse 2NBDG+ plasma cells
and genes elevated in human long-lived plasma cells (Figure 6D).
Thus, we find no evidence for an evolutionarily conserved tran-
scriptional signature associated with enhanced glucose uptake
or plasma cell longevity.
Pathway overrepresentation analyses on individual compari-
sons between plasma cell subsets revealed elevations in cell-cy-
cle gene expression in B220+2NBDG cells and, unexpectedly,
an elevation in neutrophil degranulation genes in bone marrow
plasma cells (Figure 6E). This was surprising given that Ly6g-
and CD11c-expressing neutrophils and other myeloid cells
were specifically excluded from the cells sorted for RNA-seq.
Because the levels of transcripts for many of these neutrophil
degranulation genes were low, the data suggested that poten-
tially only a subset of plasma cells expressed this unusual
signature.
Single-Cell RNA-Sequencing Reveals Plasma Cell
Subsets with Distinct Isotypes and Antimicrobial
Peptide Expression
We next performed single-cell RNA-seq on approximately 1,000
cells of each plasma cell subset to define transcriptional hetero-
geneity. Igk constant region transcripts represented an average
of 30% of the total transcriptome of each cell (Figure S6A),
consistent with previous plasma cell RNA-seq studies (Shi
et al., 2015). Other plasma cell markers including IGJ (Rinken-
berger et al., 1996), LY6A/E (Wilmore et al., 2017), TNFRSF13B
(Pracht et al., 2017), and XBP1 (Reimold et al., 2001) were highly
expressed, confirming the identity and purity of these cells (Fig-
ures S6A and S6B).
After excluding immunoglobulin transcripts, t-distributed sto-
chastic neighbor embedding (t-SNE) analysis on concatenated
sequences revealed nine clusters (Figure 7A). Three hundred
fifty-two genes were preferentially expressed (p < 0.1, t test
with Benjamini-Hochberg correction for multiple tests) by at
least one cluster relative to the rest of the population. Pearson
distance measurements using this set of genes revealed that
clusters 9 and 6 were related and distinct from each of the
other clusters (Figure 7B). The remaining clusters were distin-
guished from one another by a much smaller group of genes
(Figure 7B). We next overlaid data points from each plasma
cell population onto the t-SNE plot to determine the composi-
tion of each subset and cluster (Figure 7C). The B220+2NBDG
subset, which is the shortest lived plasma cell population (Fig-
ure 1A), was mainly distributed between the unique clusters 6
and 9 (Figures 7C and S6C). In contrast, the long-lived bone
marrow plasma cell subset was concentrated in clusters 1
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and 5 (Figures 7C and S6C). Each of the other plasma cell pop-
ulations showed more heterogeneous distributions across the
clusters (Figures 7C and S6C). These data demonstrate that
despite marked metabolic differences, each plasma cell sub-
set, defined by B220 expression and 2NBDG uptake, is distrib-
uted across most of these transcriptionally defined clusters.
Thus, plasma cell metabolic properties do not correlate with
transcriptional profiles.
To determine how this transcriptional heterogeneity relates to
other markers and strategies to separate plasma cell subsets
that have been used by others, we examined expression of
CD93, major histocompatibility complex class II (MHC class II),
Figure 6. Transcriptional Profiles Are Similar between Plasma Cell Subsets
(A) RNA-seq analysis of gene transcript levels between B2202NBDG versus B2202NBDG+, B220+2NBDG versus B220+2NBDG+, or B2202NBDG versus
BM. Volcano plots of gene expression fold changes between 2NBDG+ and 2NBDG populations are shown. Adjusted p values were calculated using DESeq2,
with red and blue boxes representing genes that are significantly upregulated or downregulated, respectively, in 2NBDG+ cells. Each dot represents a single
gene. Three biological replicates were analyzed for each population.
(B) Venn diagram analysis of common transcripts either upregulated (left) or downregulated (right) in 2NBDG+ populations.
(C) RNA-seq analysis of gene transcript levels between human CD19+ short-lived plasma cells (SLPCs) and CD19 long-lived plasma cells (LLPCs). Volcano plot
analysis of differential transcript expression between human LLPCs and SLPCs is shown. Each dot represents a single gene. Four biological replicates were
analyzed for each population. Adjusted p values were calculated using DESeq2. Each dot represents a single gene. Four biological replicates were analyzed for
each population.
(D) Little overlap between overexpressed genes in 2NBDG+murine and human long-lived plasma cell populations (top) or 2NBDGmurine and human short-lived
plasma cell populations (bottom).
(E) Pathway analysis of genes downregulated in bone marrow plasma cells. Heatmap representation of genes and their expression across each biological
replicate of each plasma cell population. Color scale legend depicts row-normalized Z scores.
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CXCR3, and mKi67. CD93 mRNA expression did not uniquely
associate with or exclude any clusters (Figure 7D). MHC class
II/H2-Aa and CXCR3, which mark BLIMP1low plasmablasts (Kal-
lies et al., 2004; Shi et al., 2015), were preferentially expressed by
clusters 6 and 9 (Figure 7D). In contrast, the proliferation marker
mKi67 was expressed primarily in cluster 9 (Figure 7D). Other
markers, such as CD19 and BLIMP1 itself (Chernova et al.,
2014; Kallies et al., 2004; Pracht et al., 2017), were near the lower
limit of detection for single-cell RNA-seq, which captures only
10%ofmRNAs (Macosko et al., 2015), and thus did not resolve
the populations further (Figure S6B).
We next used all 352 genes that were preferentially and statis-
tically significantly expressed by at least one cluster to perform
over-representation analysis, using the Consensus Pathway
database (Herwig et al., 2016), to determine the biological signif-
icance of the heterogeneity. Biological pathways that were
significantly over-represented (q value < 105) included transla-
tion, ER protein processing, cell cycle, mRNA splicing, electron
transport chain, proteasome, and, as noted above, neutrophil
Figure 7. Plasma Cell Transcriptional Het-
erogeneity Is Defined by Proliferative Genes
and Neutrophil Degranulation Pathways
(A) t-SNE analysis of single-cell RNA-seq data
concatenated from all plasma cell subsets. Each
data point represents one cell, and nine identified
clusters are depicted in distinct colors.
(B) All 352 genes were plotted that were statistically
significantly and preferentially expressed by at least
one cluster relative to the remaining population
(adjusted p < 0.1, Benjamini-Hochberg test). Each
gene and cluster were ordered and grouped based
on average linkage and depicted in the corre-
sponding dendrograms. Red indicates high relative
expression, and blue indicates low expression,
shown as row-normalized Z scores.
(C) Data points from each plasma cell subset were
overlaid as dark blue dots onto the concatenated
t-SNE plot.
(D) Expression of plasma cell marker genes are
depicted as a heatmap overlaid onto the concate-
nated t-SNE plot.
(E) Pathway analysis of 352 significant cluster-
specific genes. These genes were over-repre-
sented in translation, cell cycle, electron transport
chain, ER protein processing, mRNA splicing, pro-
teasome, and neutrophil degranulation pathways
as analyzed using the Consensus Pathway data-
base (q value < 105). Red indicates high relative
expression, and blue indicates low expression,
shown as row-normalized Z scores.
degranulation (Figure 7E). Clusters 6 and
9, which compose most of the short-lived
B220+2NBDG subset (Figure 7D), prefer-
entially expressed genes in the translation,
ER protein processing, electron transport
chain, and proteasome pathways (Fig-
ure 7E). Clusters 6 and 9 were distin-
guished from each other by genes
involved in cell-cycle and mRNA splicing
(Figure 7E), consistent with mKi67 expression observed in clus-
ter 9 (Figure 7D). These data suggest that cluster 9 is composed
of proliferative B220+2NBDG plasmablasts, whereas cluster 6
is composed of non-cycling B220+2NBDG cells. Indeed, re-
ports by others and our own previous data suggest that a subset
of the B220+ plasma cells is proliferative (Chernova et al., 2014;
Lam et al., 2016). As above in Figure 6E, only the neutrophil
degranulation pathway was able to distinguish the remaining
clusters (Figure 7E). Other highly expressed granulocyte tran-
scripts such as CSF3R and LY6G were undetectable (Fig-
ure S6B), arguing against neutrophil contamination.
Inclusion of immunoglobulin constant region genes in the sin-
gle-cell RNA sequencing (scRNA-seq) analysis revealed differ-
ences in isotype usage across plasma cell subsets. For example,
75% of B2202NBDG plasma cells used IgM, whereas nearly
60% of bone marrow plasma cells were IgA+ (Figure S6D),
consistent with previous reports (Wilmore et al., 2018). However,
each isotype was observed at some frequency in every plasma
cell subset, demonstrating that antibody class does not strictly
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define plasma cell longevity or metabolic programs. Expression
of neutrophil degranulation genes correlated somewhat with
antibody isotype (Figure S6E), but in none of these cases was
this correlation absolute. For example, IgG1+ plasma cells ex-
pressed on average higher levels of Slpi than did IgM+ plasma
cells (Figure S6E). However, a small subset of IgM+ cells ex-
pressed very high levels ofSlpi (Figure S6F). Thus, transcriptional
programs and antibody isotype independently diversify plasma
cell function.
DISCUSSION
Plasma cells vary greatly in lifespan, depending on the type of
infection or vaccine, the timing of ontogeny, and their anatom-
ical location. Defining pathways that promote plasma cell
longevity is a major goal for vaccine development, especially
for immunizations that lead to very transient protection against
infections. Reciprocally, identifying ways to antagonize long-
lived plasma cells in the context of multiple myeloma and auto-
immunity is also an important clinical goal. We observed that
fluorescent glucose analog uptake correlates with plasma cell
lifespan and allows for further purification and prospective
isolation of long- and short-lived subsets when coupled with
B220 expression. The usage of fluorescent glucose uptake
thus helps facilitate the prospective isolation of short- and
long-lived plasma cells.
Clearly, however, much still remains unresolved regarding the
mechanisms of plasma cell survival. Although glucose uptake
correlates with plasma cell longevity, it does not fully explain
the heterogeneity. We observed substantial differences in life-
spans among plasma cells that import the same amount of
glucose. This led us to explore other pathways, such as ER
stress and transcriptional regulation of survival genes, which
may integrate with metabolism and nutrient uptake to tune
plasma cell lifespan. Yet against all our predictions, we found
almost no consistent changes in ER stress or transcription
between mouse long- and short-lived plasma cell subsets.
Although transcriptional changes are essential during plasma-
blast differentiation to establish a metabolic program (Guo
et al., 2018; Jash et al., 2016; Price et al., 2018; Wang and Bhat-
tacharya, 2014), these changes seem not to further distinguish
mature plasma cell subsets (Valor et al., 2017).
The transcriptional changes we did observe were mainly
linked to cell proliferation and, unexpectedly, genes traditionally
involved in neutrophil effector functions. Although we observed
no evidence of neutrophil-like granules in plasma cells, it is
possible that these proteins are constitutively released and allow
certain plasma cell subsets to perform non-canonical effector
functions to help clear pathogens and resolve damage. Such
properties are reminiscent of tumor necrosis factor alpha
(TNF-a)- and inducible nitric oxide synthase (iNOS)-producing
IgA+ plasma cells in the intestine, which help maintain microbial
homeostasis (Fritz et al., 2011). iNOS itself promotes plasma cell
survival (Saini et al., 2014), yet it seems unlikely that the innate
immune pathways identified here would be directly tied to
plasma cell lifespan given that the differences are not correlated
with metabolic properties. The functional importance of these
unusual signatures clearly needs to be explored more deeply.
The major pathways that consistently distinguish long- from
short-lived plasma cells are non-transcriptional. Long-lived
plasma cells that import high levels of glucose and also express
high cell surface levels of CD98, a common subunit to many
amino acid transporters (Mastroberardino et al., 1998), are less
sensitive to reductions in extracellular amino acid concentrations
and secrete more antibodies than do their short-lived counter-
parts. As in human long-lived plasma cells (Halliley et al.,
2015), mouse long-lived plasma cells also have elevated
autophagosome content. Glucose is used predominantly to
glycosylate antibodies, but also to generate pyruvate for spare
respiratory capacity, which in turn promotes survival (Lam
et al., 2016). Similarly, glutamine is used as a carbon source
for mitochondrial anaplerotic reactions and respiration, as well
as a building block for antibodies. Together, our findings suggest
a metabolic link between antibody secretion and lifespan. The
discovery of new pathways that enhance or unlink these proper-
ties can potentially be exploited to prolong immunity or antago-
nize autoimmunity and plasma cell malignancies.
STAR+METHODS
Detailed methods are provided in the online version of this paper
and include the following:
d KEY RESOURCES TABLE
d CONTACT FOR REAGENT AND RESOURCE SHARING
d EXPERIMENTAL MODEL AND SUBJECT DETAILS
d METHOD DETAILS
B Tissue Processing
B Bone Marrow Chimeras
B Plasma Cell Cultures
B Bromodeoxyuridine Experiments
B Immunizations
B ELISAs
B Flow Cytometry/Sorting
B qRT-PCR
B Electron Microscopy
B In Vivo Ribopuromycylation
B CaspGLOW Assay
B Immunoglobulin Repertoire Analysis
B RNA-Seq
B Single-Cell RNA-Seq
B
13C Tracing Experiments
d QUANTIFICATION AND STATISTICAL ANALYSIS
d DATA AND SOFTWARE AVAILABILITY
SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures and can be found with this
article online at https://doi.org/10.1016/j.celrep.2018.07.084.
ACKNOWLEDGMENTS
This work was supported by NIH grants R01AI099108 and R01AI129945 (to
D.B.), R01ES022181 (to G.J.P.), and R01NS099304 (to G.P.M.). This work
was also supported by a Robertson Investigator award from The New York
Stem Cell Foundation (to D.B.). R.W. was supported by a predoctoral fellow-
ship from the National Science Foundation (DGE-1143954). We thank the
Genome Technology Access Center in the Department of Genetics at
Cell Reports 24, 2479–2492, August 28, 2018 2489
Washington University School of Medicine for help with genomic analysis. The
Center is partially supported by NCI Cancer Center Support Grant P30
CA91842 to the Siteman Cancer Center and by ICTS/CTSA Grant
UL1TR000448 from the National Center for Research Resources (NCRR), a
component of the NIH, and NIH Roadmap for Medical Research. This publica-
tion is solely the responsibility of the authors and does not necessarily repre-
sent the official view of NCRR or NIH.
AUTHOR CONTRIBUTIONS
W.Y.L., G.P.M., G.J.P., and D.B. designed the study. W.Y.L., A.J., C.H.-Y.,
L.D., R.M.N., and D.B. performed experiments. W.Y.L., A.J., C.-H.Y., L.D.,
R.W., G.J.P., and D.B. analyzed the data. W.Y.L. and D.B. wrote the paper,
and all other authors edited the paper.
DECLARATION OF INTERESTS
D.B. is a co-founder of Cloak Therapeutics and owns significant equity. A pat-
ent application related to the current work has been filed (PCT/US18/23288).
G.J.P. is a scientific advisory board member for Cambridge Isotope
Laboratories. R.M.N. is a paid consultant for Biocomposites, Cardinal Health;
CardioMEMS; DePuy, A Johnson & Johnson Company; Integra Sciences;
Medtronic; Smith & Nephew; and Wright Medical Technology, Inc. W.Y.L. is
an employee of Amgen Inc.
Received: February 28, 2018
Revised: June 15, 2018
Accepted: July 25, 2018
Published: August 28, 2018
REFERENCES
Amanna, I.J., Carlson, N.E., and Slifka, M.K. (2007). Duration of humoral
immunity to common viral and vaccine antigens. N. Engl. J. Med. 357,
1903–1915.
An, M., Ryu, D.R., Won Park, J., Ha Choi, J., Park, E.M., Eun Lee, K., Woo, M.,
and Kim, M. (2017). ULK1 prevents cardiac dysfunction in obesity through
autophagy-meditated regulation of lipid metabolism. Cardiovasc. Res. 113,
1137–1147.
Aragon, I.V., Barrington, R.A., Jackowski, S., Mori, K., andBrewer, J.W. (2012).
The specialized unfolded protein response of B lymphocytes: ATF6a-inde-
pendent development of antibody-secreting B cells. Mol. Immunol. 51,
347–355.
Auner, H.W., Beham-Schmid, C., Dillon, N., and Sabbattini, P. (2010). The life
span of short-lived plasma cells is partly determined by a block on activation of
apoptotic caspases acting in combination with endoplasmic reticulum stress.
Blood 116, 3445–3455.
Axten, J.M., Romeril, S.P., Shu, A., Ralph, J., Medina, J.R., Feng, Y., Li, W.H.,
Grant, S.W., Heerding, D.A., Minthorn, E., et al. (2013). Discovery of
GSK2656157: an optimized PERK inhibitor selected for preclinical develop-
ment. ACS Med. Chem. Lett. 4, 964–968.
Bolotin, D.A., Poslavsky, S., Mitrophanov, I., Shugay, M., Mamedov, I.Z., Pu-
tintseva, E.V., and Chudakov, D.M. (2015). MiXCR: software for comprehen-
sive adaptive immunity profiling. Nat. Methods 12, 380–381.
Bortnick, A., Chernova, I., Quinn,W.J., 3rd,Mugnier, M., Cancro, M.P., and All-
man, D. (2012). Long-lived bone marrow plasma cells are induced early in
response to T cell-independent or T cell-dependent antigens. J. Immunol.
188, 5389–5396.
Cantor, J., Browne, C.D., Ruppert, R., Fe´ral, C.C., Fa¨ssler, R., Rickert, R.C.,
and Ginsberg, M.H. (2009). CD98hc facilitates B cell proliferation and adaptive
humoral immunity. Nat. Immunol. 10, 412–419.
Chernova, I., Jones, D.D., Wilmore, J.R., Bortnick, A., Yucel, M., Hershberg,
U., and Allman, D. (2014). Lasting antibody responses are mediated by a com-
bination of newly formed and established bone marrow plasma cells drawn
from clonally distinct precursors. J. Immunol. 193, 4971–4979.
Chevrier, S., Genton, C., Kallies, A., Karnowski, A., Otten, L.A., Malissen, B.,
Malissen, M., Botto, M., Corcoran, L.M., Nutt, S.L., and Acha-Orbea, H.
(2009). CD93 is required for maintenance of antibody secretion and persis-
tence of plasma cells in the bone marrow niche. Proc. Natl. Acad. Sci. USA
106, 3895–3900.
Chillaro´n, J., and Haas, I.G. (2000). Dissociation from BiP and retrotransloca-
tion of unassembled immunoglobulin light chains are tightly coupled to protea-
some activity. Mol. Biol. Cell 11, 217–226.
Fagard, R., and London, I.M. (1981). Relationship between phosphorylation
and activity of heme-regulated eukaryotic initiation factor 2 alpha kinase.
Proc. Natl. Acad. Sci. USA 78, 866–870.
Fa¨hnrich, A., Krebbel, M., Decker, N., Leucker, M., Lange, F.D., Kalies, K., and
Mo¨ller, S. (2017). ClonoCalc and ClonoPlot: immune repertoire analysis from
raw files to publication figures with graphical user interface. BMC Bioinformat-
ics 18, 164.
Fritz, J.H., Rojas, O.L., Simard, N., McCarthy, D.D., Hapfelmeier, S., Rubino,
S., Robertson, S.J., Larijani, M., Gosselin, J., Ivanov, I.I., et al. (2011). Acquisi-
tion of a multifunctional IgA+ plasma cell phenotype in the gut. Nature 481,
199–203.
Garcia-Manteiga, J.M., Mari, S., Godejohann, M., Spraul, M., Napoli, C.,
Cenci, S., Musco, G., and Sitia, R. (2011). Metabolomics of B to plasma cell
differentiation. J. Proteome Res. 10, 4165–4176.
Gass, J.N., Jiang, H.Y., Wek, R.C., and Brewer, J.W. (2008). The unfolded pro-
tein response of B-lymphocytes: PERK-independent development of anti-
body-secreting cells. Mol. Immunol. 45, 1035–1043.
Guo, M., Price, M.J., Patterson, D.G., Barwick, B.G., Haines, R.R., Kania, A.K.,
Bradley, J.E., Randall, T.D., Boss, J.M., and Scharer, C.D. (2018). EZH2 re-
presses the B cell transcriptional program and regulates antibody-secreting
cell metabolism and antibody production. J. Immunol. 200, 1039–1052.
Guthrie, L.N., Abiraman, K., Plyler, E.S., Sprenkle, N.T., Gibson, S.A.,
McFarland, B.C., Rajbhandari, R., Rowse, A.L., Benveniste, E.N., and Meares,
G.P. (2016). Attenuation of PKR-like ER kinase (PERK) signaling selectively
controls endoplasmic reticulum stress-induced inflammation without compro-
mising immunological responses. J. Biol. Chem. 291, 15830–15840.
Halliley, J.L., Tipton, C.M., Liesveld, J., Rosenberg, A.F., Darce, J., Gregoretti,
I.V., Popova, L., Kaminiski, D., Fucile, C.F., Albizua, I., et al. (2015). Long-lived
plasma cells are contained within the CD19(-)CD38(hi)CD138(+) subset in
human bone marrow. Immunity 43, 132–145.
Herwig, R., Hardt, C., Lienhard, M., and Kamburov, A. (2016). Analyzing and
interpreting genome data at the network level with ConsensusPathDB. Nat.
Protoc. 11, 1889–1907.
Hickman, S., Kulczycki, A., Jr., Lynch, R.G., and Kornfeld, S. (1977). Studies of
the mechanism of tunicamycin in hibition of IgA and IgE secretion by plasma
cells. J. Biol. Chem. 252, 4402–4408.
Jammi, N.V., Whitby, L.R., and Beal, P.A. (2003). Small molecule inhibitors
of the RNA-dependent protein kinase. Biochem. Biophys. Res. Commun.
308, 50–57.
Jash, A., Wang, Y., Weisel, F.J., Scharer, C.D., Boss, J.M., Shlomchik, M.J.,
and Bhattacharya, D. (2016). ZBTB32 restricts the duration of memory B cell
recall responses. J. Immunol. 197, 1159–1168.
Jones, D.D., Gaudette, B.T., Wilmore, J.R., Chernova, I., Bortnick, A., Weiss,
B.M., and Allman, D. (2016). mTOR has distinct functions in generating versus
sustaining humoral immunity. J. Clin. Invest. 126, 4250–4261.
Kallies, A., Hasbold, J., Tarlinton, D.M., Dietrich, W., Corcoran, L.M., Hodgkin,
P.D., and Nutt, S.L. (2004). Plasma cell ontogeny defined by quantitative
changes in blimp-1 expression. J. Exp. Med. 200, 967–977.
Lam, W.Y., and Bhattacharya, D. (2018). Metabolic links between plasma cell
survival, secretion, and stress. Trends Immunol. 39, 19–27.
Lam, W.Y., Becker, A.M., Kennerly, K.M., Wong, R., Curtis, J.D., Llufrio, E.M.,
McCommis, K.S., Fahrmann, J., Pizzato, H.A., Nunley, R.M., et al. (2016). Mito-
chondrial pyruvate import promotes long-term survival of antibody-secreting
plasma cells. Immunity 45, 60–73.
2490 Cell Reports 24, 2479–2492, August 28, 2018
Lehninger, A.L., Nelson, D.L., and Cox, M.M. (2013). Lehninger Principles of
Biochemistry, Sixth Edition (W.H. Freeman).
Love, M.I., Huber, W., and Anders, S. (2014). Moderated estimation of fold
change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550.
Ma, Y., Shimizu, Y., Mann, M.J., Jin, Y., and Hendershot, L.M. (2010). Plasma
cell differentiation initiates a limited ER stress response by specifically sup-
pressing the PERK-dependent branch of the unfolded protein response. Cell
Stress Chaperones 15, 281–293.
Macosko, E.Z., Basu, A., Satija, R., Nemesh, J., Shekhar, K., Goldman, M., Tir-
osh, I., Bialas, A.R., Kamitaki, N., Martersteck, E.M., et al. (2015). Highly
parallel genome-wide expression profiling of individual cells using nanoliter
droplets. Cell 161, 1202–1214.
Manz, R.A., Lo¨hning, M., Cassese, G., Thiel, A., and Radbruch, A. (1998). Sur-
vival of long-lived plasma cells is independent of antigen. Int. Immunol. 10,
1703–1711.
Mastroberardino, L., Spindler, B., Pfeiffer, R., Skelly, P.J., Loffing, J., Shoe-
maker, C.B., and Verrey, F. (1998). Amino-acid transport by heterodimers of
4F2hc/CD98 and members of a permease family. Nature 395, 288–291.
Menzel, U., Greiff, V., Khan, T.A., Haessler, U., Hellmann, I., Friedensohn, S.,
Cook, S.C., Pogson, M., and Reddy, S.T. (2014). Comprehensive evaluation
and optimization of amplicon library preparation methods for high-throughput
antibody sequencing. PLoS ONE 9, e96727.
Mielke, N., Schwarzer, R., Calkhoven, C.F., Kaufman, R.J., Do¨rken, B., Leutz,
A., and Jundt, F. (2011). Eukaryotic initiation factor 2alpha phosphorylation
is required for B-cell maturation and function in mice. Haematologica 96,
1261–1268.
Minges Wols, H.A., Underhill, G.H., Kansas, G.S., and Witte, P.L. (2002). The
role of bone marrow-derived stromal cells in the maintenance of plasma cell
longevity. J. Immunol. 169, 4213–4221.
O’Connor, B.P., Raman, V.S., Erickson, L.D., Cook, W.J., Weaver, L.K., Aho-
nen, C., Lin, L.L., Mantchev, G.T., Bram, R.J., and Noelle, R.J. (2004). BCMA is
essential for the survival of long-lived bone marrow plasma cells. J. Exp. Med.
199, 91–98.
Oslowski, C.M., and Urano, F. (2011). Measuring ER stress and the unfolded
protein response using mammalian tissue culture system. Methods Enzymol.
490, 71–92.
Patro, R., Duggal, G., Love, M.I., Irizarry, R.A., and Kingsford, C. (2017).
Salmon provides fast and bias-aware quantification of transcript expression.
Nat. Methods 14, 417–419.
Pengo, N., Scolari, M., Oliva, L., Milan, E., Mainoldi, F., Raimondi, A., Fagioli,
C., Merlini, A., Mariani, E., Pasqualetto, E., et al. (2013). Plasma cells require
autophagy for sustainable immunoglobulin production. Nat. Immunol. 14,
298–305.
Peperzak, V., Vikstro¨m, I., Walker, J., Glaser, S.P., LePage, M., Coquery, C.M.,
Erickson, L.D., Fairfax, K., Mackay, F., Strasser, A., et al. (2013). Mcl-1 is
essential for the survival of plasma cells. Nat. Immunol. 14, 290–297.
Pracht, K., Meinzinger, J., Daum, P., Schulz, S.R., Reimer, D., Hauke, M., Roth,
E., Mielenz, D., Berek, C., Co^rte-Real, J., et al. (2017). A new staining protocol
for detection of murine antibody-secreting plasma cell subsets by flow cytom-
etry. Eur. J. Immunol. 47, 1389–1392.
Price, M.J., Patterson, D.G., Scharer, C.D., and Boss, J.M. (2018). Progressive
upregulation of oxidative metabolism facilitates plasmablast differentiation to
a T-independent antigen. Cell Rep. 23, 3152–3159.
Reimold, A.M., Iwakoshi, N.N., Manis, J., Vallabhajosyula, P., Szomolanyi-
Tsuda, E., Gravallese, E.M., Friend, D., Grusby, M.J., Alt, F., and Glimcher,
L.H. (2001). Plasma cell differentiation requires the transcription factor XBP-
1. Nature 412, 300–307.
Reynolds, A.E., Kuraoka, M., and Kelsoe, G. (2015). Natural IgM is produced
by CD5- plasma cells that occupy a distinct survival niche in bone marrow.
J. Immunol. 194, 231–242.
Rinkenberger, J.L., Wallin, J.J., Johnson, K.W., and Koshland, M.E. (1996). An
interleukin-2 signal relieves BSAP (Pax5)-mediated repression of the immuno-
globulin J chain gene. Immunity 5, 377–386.
Robert, F., Williams, C., Yan, Y., Donohue, E., Cencic, R., Burley, S.K., and
Pelletier, J. (2009). Blocking UV-induced eIF2alpha phosphorylation with small
molecule inhibitors of GCN2. Chem. Biol. Drug Des. 74, 57–67.
Ron, D., and Walter, P. (2007). Signal integration in the endoplasmic reticulum
unfolded protein response. Nat. Rev. Mol. Cell Biol. 8, 519–529.
Rozanski, C.H., Arens, R., Carlson, L.M., Nair, J., Boise, L.H., Chanan-Khan,
A.A., Schoenberger, S.P., and Lee, K.P. (2011). Sustained antibody responses
depend on CD28 function in bone marrow-resident plasma cells. J. Exp. Med.
208, 1435–1446.
Saini, A.S., Shenoy, G.N., Rath, S., Bal, V., and George, A. (2014). Inducible
nitric oxide synthase is a major intermediate in signaling pathways for the sur-
vival of plasma cells. Nat. Immunol. 15, 275–282.
Savage, H.P., Yenson, V.M., Sawhney, S.S., Mousseau, B.J., Lund, F.E., and
Baumgarth, N. (2017). Blimp-1-dependent and -independent natural
antibody production by B-1 and B-1-derived plasma cells. J. Exp. Med. 214,
2777–2794.
Scheuner, D., Song, B., McEwen, E., Liu, C., Laybutt, R., Gillespie, P., Saun-
ders, T., Bonner-Weir, S., and Kaufman, R.J. (2001). Translational control is
required for the unfolded protein response and in vivo glucose homeostasis.
Mol. Cell 7, 1165–1176.
Seedhom, M.O., Hickman, H.D., Wei, J., David, A., and Yewdell, J.W. (2016).
Protein translation activity: a new measure of host immune cell activation.
J. Immunol. 197, 1498–1506.
Shi, W., Liao, Y., Willis, S.N., Taubenheim, N., Inouye, M., Tarlinton, D.M.,
Smyth, G.K., Hodgkin, P.D., Nutt, S.L., and Corcoran, L.M. (2015). Transcrip-
tional profiling of mouse B cell terminal differentiation defines a signature for
antibody-secreting plasma cells. Nat. Immunol. 16, 663–673.
Slifka, M.K., Antia, R.,Whitmire, J.K., and Ahmed, R. (1998). Humoral immunity
due to long-lived plasma cells. Immunity 8, 363–372.
Sze, D.M., Toellner, K.M., Garcı´a de Vinuesa, C., Taylor, D.R., andMacLennan,
I.C. (2000). Intrinsic constraint on plasmablast growth and extrinsic limits of
plasma cell survival. J. Exp. Med. 192, 813–821.
Taubenheim, N., Tarlinton, D.M., Crawford, S., Corcoran, L.M., Hodgkin, P.D.,
and Nutt, S.L. (2012). High rate of antibody secretion is not integral to plasma
cell differentiation as revealed by XBP-1 deficiency. J. Immunol. 189, 3328–
3338.
Tellier, J., Shi, W., Minnich, M., Liao, Y., Crawford, S., Smyth, G.K., Kallies, A.,
Busslinger, M., and Nutt, S.L. (2016). Blimp-1 controls plasma cell function
through the regulation of immunoglobulin secretion and the unfolded protein
response. Nat. Immunol. 17, 323–330.
Thompson, R.M., Dytfeld, D., Reyes, L., Robinson, R.M., Smith, B., Manevich,
Y., Jakubowiak, A., Komarnicki, M., Przybylowicz-Chalecka, A., Szczepaniak,
T., et al. (2017). Glutaminase inhibitor CB-839 synergizes with carfilzomib in
resistant multiple myeloma cells. Oncotarget 8, 35863–35876.
Tiller, T., Busse, C.E., and Wardemann, H. (2009). Cloning and expression of
murine Ig genes from single B cells. J. Immunol. Methods 350, 183–193.
Valor, L.M., Rodrı´guez-Bayona, B., Ramos-Amaya, A.B., Brieva, J.A., and
Campos-Caro, A. (2017). The transcriptional profiling of human in vivo-gener-
ated plasma cells identifies selective imbalances in monoclonal gammopa-
thies. PLoS ONE 12, e0183264.
Wang, Y., and Bhattacharya, D. (2014). Adjuvant-specific regulation of long-
term antibody responses by ZBTB20. J. Exp. Med. 211, 841–856.
Weisel, F.J., Zuccarino-Catania, G.V., Chikina,M., and Shlomchik, M.J. (2016).
A temporal switch in the germinal center determines differential output of
memory B and plasma cells. Immunity 44, 116–130.
Weiss, G.E., Traore, B., Kayentao, K., Ongoiba, A., Doumbo, S., Doumtabe, D.,
Kone, Y., Dia, S., Guindo, A., Traore, A., et al. (2010). The Plasmodium falcip-
arum-specific human memory B cell compartment expands gradually with
repeated malaria infections. PLoS Pathog. 6, e1000912.
White, M.T., Verity, R., Griffin, J.T., Asante, K.P., Owusu-Agyei, S., Green-
wood, B., Drakeley, C., Gesase, S., Lusingu, J., Ansong, D., et al. (2015).
Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for
Cell Reports 24, 2479–2492, August 28, 2018 2491
duration of vaccine efficacy: secondary analysis of data from a phase 3
randomised controlled trial. Lancet Infect. Dis. 15, 1450–1458.
Wilmore, J.R., Jones, D.D., and Allman, D. (2017). Protocol for improved res-
olution of plasma cell subpopulations by flow cytometry. Eur. J. Immunol. 47,
1386–1388.
Wilmore, J.R., Gaudette, B.T., Gomez Atria, D., Hashemi, T., Jones, D.D.,
Gardner, C.A., Cole, S.D., Misic, A.M., Beiting, D.P., and Allman, D. (2018).
Commensal microbes induce serum IgA responses that protect against poly-
microbial sepsis. Cell Host Microbe. 23, 302–311.e3.
Winter, O., Dame, C., Jundt, F., and Hiepe, F. (2012). Pathogenic long-lived
plasma cells and their survival niches in autoimmunity, malignancy, and
allergy. J. Immunol. 189, 5105–5111.
Yang, Y., Wang, C., Yang, Q., Kantor, A.B., Chu, H., Ghosn, E.E., Qin, G., Maz-
manian, S.K., Han, J., and Herzenberg, L.A. (2015). Distinct mechanisms
define murine B cell lineage immunoglobulin heavy chain (IgH) repertoires.
eLife 4, e09083.
Yao, C.H., Fowle-Grider, R., Mahieu, N.G., Liu, G.Y., Chen, Y.J., Wang, R.,
Singh, M., Potter, G.S., Gross, R.W., Schaefer, J., et al. (2016). Exogenous
fatty acids are the preferred source of membrane lipids in proliferating fibro-
blasts. Cell Chem. Biol. 23, 483–493.
Yoshioka, K., Saito, M., Oh, K.B., Nemoto, Y., Matsuoka, H., Natsume,M., and
Abe, H. (1996). Intracellular fate of 2-NBDG, a fluorescent probe for glucose
uptake activity, in Escherichia coli cells. Biosci. Biotechnol. Biochem. 60,
1899–1901.
Zacharogianni, M., Kondylis, V., Tang, Y., Farhan, H., Xanthakis, D., Fuchs, F.,
Boutros, M., and Rabouille, C. (2011). ERK7 is a negative regulator of protein
secretion in response to amino-acid starvation by modulating Sec16 mem-
brane association. EMBO J. 30, 3684–3700.
Zinkernagel, R.M., and Hengartner, H. (2006). Protective ‘immunity’ by pre-
existent neutralizing antibody titers and preactivated T cells but not by so-
called ‘immunological memory’. Immunol. Rev. 211, 310–319.
2492 Cell Reports 24, 2479–2492, August 28, 2018
STAR+METHODS
KEY RESOURCES TABLE
REAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
CD138 (PE conjugate) Biolegend Catalog 352306; RRID:AB_10915989
Donkey Anti-Mouse IgG (H+L)-biotin conjugate Jackson Immunoresearch 709-065-149; RRID:AB_2340507
streptavidin horseradish peroxidase BD Biosciences 554066
B220-allophycocyanin (APC)-Cy7 Biolegend 103224; RRID:AB_313007
CD93-PE-Cy7 Biolegend 136506; RRID:AB_2044012
p-S6-V450 BD Biosciences 561457; RRID:AB_10643763
p-eIF2a-Alexa 647 Abcam ab196191
Igk-PE-Cy7 BD Biosciences 560667; RRID:AB_1727535
CD45.2-BV510 Biolegend 109837; RRID:AB_2561393
CD45.1-BV605 Biolegend 110738; RRID:AB_2562565
Puromycin Developmental Studies
Hybridoma Bank
PMY-2A4; RRID:AB_2619605
biotin mouse anti-mouse IgG2a[b] BD Biosciences 553504; RRID:AB_394889
BV605 Streptavidin Biolegend 405229
Chemicals, Peptides, and Recombinant Proteins
Puromycin EMD Millipore 540222
Histopaque 1119 Sigma 11191
GSK2606414 Sigma 516535
SP600125 Sigma S5567
indirubin-30-monoxime Sigma 402086
imidazole-oxindole C16 Sigma I2399
Hemin Sigma 51280
aluminum potassium sulfate Fisher S70459
NP-Ova Biosearch N-5051
4-hydroxy-3-nitrophenylacetyl-O-succinimide ester Biosearch 10634
Allophycocyanin Sigma A7472
3,30,5,50- Tetramethulbenzidine dihydrochloride hydrate Dako S1599
paraformaldehyde Electron Microscopy
Services
15710
Saponin Sigma 84510
13C-U-glucose Cambridge Isotopes CLM-1396
13C-U-glutamine Cambridge Isotopes CLM-1822
tamoxifen-containing chow Envigo TD.130860
Cycloheximide Fisher NC0667720
2NBDG Cayman Chemicals 11046
Critical Commercial Assays
CD138 enrichment beads Miltenyi 130-051-301
anti-PE microbeads Miltenyi 130-048-801
LS columns Miltenyi 130-042-401
Autophagy Assay kit Sigma MAK138
FITC BrdU Flow kit BD Biosciences BDB557891
NucleoSpin RNA isolation kit Macherey-Nagel 740902.50
SYBR Green PCR master mix Applied Biosystems 4309155
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Superscript III Reverse transcription kit Thermo Fisher 18080400
CaspGLOW 12 staining kit Biovision K172-25
SMART-Seq v4 Clontech 634888
Nextera XT DNA library kit Illumina 131-1024
Chromium Single Cell 30 Library & Gel Bead Kit 10x Genomics 120237
Deposited Data
RNA-seq data This paper NCBI GEO: GSE115860
Single cell RNA seq data This paper NCBI GEO: GSE115860
Experimental Models: Organisms/Strains
Mouse: C57BL/6N Charles River Labs Strain code 027
Mouse: B6-Ly5.1/Cr Charles River Labs Strain code 564
Mouse: Eif2ak3-tm1.2Drc/J Jackson Labs Stock No: 023066
Mouse: B6.Cg-Tg(CAG-cre/Esr1*)5Amc/J Jackson Labs Stock No: 004682
Mouse: B6.Cg-Gpi1a Thy1a Igha/J Jackson Labs Stock No: 001317
Oligonucleotides
Primers for XBP1s: 50-CTGAGTCCGaAtCAGGTGCAG-30
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Sigma N/A
Primers for XBP1: 50-TGGCCGGGTCTGCTGAGTCCG (forward)
and 50-GTCCATGGGAAGATGTTCTG-30 (reverse)
Sigma N/A
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Sigma N/A
msVHEstdseq1 forward: 50-TCTTTCCCTACACGATCTGGGAATT
CGAGGTGCAGCTGCAGGAGTCTGG-30
Sigma N/A
common mu stdseq2 reverse 50-GTGACTGGAGTTCAGACGTG
TGCTCTTCCGATCTAGGGGGAAGACATTTGGGAAGGAC-30
Sigma N/A
P5 forward Stdseq: 50- AATGATACGGCGACCACCGAGATCTA
CAC TCTTTCCCTACACGACGC-30
Sigma N/A
P7 reverse Stdseq index: CGGCATACGAGATNNNNNNNNGTG
ACTGGAGTTCAGACGTGTGTG-30 where N represents a unique
index for multiplexing.
Sigma N/A
Cg1 reverse primer 50- GGAAGGTGTGCACCGCTGGAC-30 Tiller et al., 2009 N/A
Cg2c reverse primer 50-GGAAGGTGCACACTGGAC-30 Tiller et al., 2009 N/A
Cg2c reverse primer 50-GGAAGGTGCACACTGGAC-30 Tiller et al., 2009 N/A
Cg3 primer 50-AGACTGTGCGCACACCGCTGGAC-30 Tiller et al., 2009 N/A
common Cgamma reverse primer: 50- GTGACTGGAGTTCAGA
CGTGTGCTCTTCCGATCTCAAGGTGGATAGAGAGCATCGA
TGGGG-30
Sigma N/A
Stdseq1: 50-ACACTCTTTCCCTACACGACGCTCTTCCGATCT-30 Sigma N/A
Stdseq2: 50-GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCT-30 Sigma N/A
Index seq: 50-GATCGGAAGAGCACACGTCTGAACTCCAGTCAC-30 Sigma N/A
Primers for PERK qRT-PCR: forward 50- GAAATCTCTGACTACAT
ACGGAC-30 reverse 50- ACACTGAAATTCCACTTCTCAC-30
Sigma N/A
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CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Deepta
Bhattacharya (deeptab@email.arizona.edu).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
All animal procedures in this study were approved by the Institutional Animal Care and UseCommittee atWashington University (pro-
tocol 20160259) and at The University of Arizona (protocol 17-266). 8-12 week old mice of both sexes were used, were age- and sex-
matched for each experiment, and littermates were used and chosen randomly in all experiments. C57Bl6/N and B6-Ly5.2/Cr
(CD45.1) mice were purchased from Charles River Laboratories, IgHa allotype mice were purchased from Jackson Laboratories,
and then housed in specific pathogen-free facilities for wild-type bone marrow and splenic plasma cells. Perkfl/fl mice and
CAGG-CreERT2 mice were purchased from Jackson Laboratories. Mice were maintained under specific pathogen-free conditions.
Euthanasia was performed by administering carbon dioxide at 1.5L/minute into a 7L chamber until 1 minute after respiration ceased.
After this point, cervical dislocation was performed to ensure death.
All human sample procedures in this study were approved by the Human Research Protection Office at Washington University.
Bone marrow was obtained from total hip arthroplasty samples from patients undergoing elective surgery (Barnes Jewish Hospital).
All samples were kept anonymous with no identifying information. The sex and age of the donors were not determined.
METHOD DETAILS
Tissue Processing
For mouse long-lived plasma cells, femurs, tibiae, humerus, and pelvic bones were isolated and crushed with a mortar and pestle.
Spleens were dissected and dissociated using frosted glass microscope slides. Non-cellular debris was removed from bonemarrow
samples by gradient centrifugation for 10 minutes at 2000 g using Histopaque 1119 (Sigma-Aldrich). Interface cells were collected
and red blood cells were lysed using a 0.15 M NH4Cl, 10 mM KHCO3, 0.1 mM EDTA (pH 7.2) solution (ACK). Cells were washed and
filtered through 70-mM nylon mesh and stained with 1 mL/107 cells anti-CD138-PE (Biolegend). Antibody-bound cells were enriched
using 1 mL/107 cells anti-PE microbeads and LS columns (Miltenyi Biotec) prior to flow cytometric analysis and sorting. Human bone
marrow plasma cells were isolated using CD138 enrichment beads (Miltenyi Biotec) as previously described (Lam et al., 2016).
Continued
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Software and Algorithms
Salmon 0.9.1 https://doi.org/10.1038/
nmeth.4197
https://combine-lab.github.io/salmon/
Deseq2 2.11.40.2 https://doi.org/10.1186/
s13059-014-0550-8
https://usegalaxy.org/?tool_id=
toolshed.g2.bx.psu.edu%2Frepos%
2Fiuc%2Fdeseq2%2Fdeseq2%
2F2.11.40.2&version=2.11.40.
2&__identifer=p99wpps8cus
Cell Ranger 2.1.0 10x Genomics https://support.10xgenomics.com/
single-cell-gene-expression/software/
downloads/latest
Loupe Browser 2.0.0 10x Genomics https://support.10xgenomics.com/
single-cell-gene-expression/software/
downloads/latest
SeqGeq 1.4.0 FlowJo https://www.flowjo.com/solutions/
seqgeq/downloads
Prism 7 Graphpad https://www.graphpad.com/scientific-
software/prism/
Mixcr 2.1.3 https://doi.org/10.1038/
nmeth.3364
https://mixcr.readthedocs.io/en/latest/
install.html
Clonoplot https://doi.org/10.1186/
s12859-017-1575-2
https://bitbucket.org/ClonoSuite/
clonocalc-plot
Other
Custom physiological RPMI media Thermo Fisher Lam et al., 2016
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Bone Marrow Chimeras
For competitive reconstitutions, 5 3 106 bone marrow cells from either Perkfl/fl or Perkfl/fl:CAGG CreER littermates were mixed with
5 3 106 bone marrow cells from B6.Ly5.2 CD45.1+ mice and injected retro-orbitally into isoflurane-anesthetized 800 cGy-irradiated
B6.Ly5.2 CD45.1+ recipients. At 8 weeks post-transplant, mice were fed tamoxifen-containing chow (400 citrate; Envigo) for 2 weeks
before sacrifice and analysis.
Plasma Cell Cultures
Sorted plasma cells were cultured overnight (18-20 hours) in hypoxic conditions (37C, 5%CO2, 5%O2) in 100ul of indicated media.
Physiological amino acid media is a custom preparation supplemented with 1% penicillin/streptomycin solution, 10% FBS, and
either 5mM or 25mM glucose as indicated and previously described (Lam et al., 2016). Supraphysiological amino acid media refers
to RPMI 1640 (Corning Cellgro 90-022-PB). For p-eIF2a inhibition experiments, cells were cultured for 1 hr in the presence of 4 nM
GSK2606414 (for PERK inhibition; Sigma-Aldrich [Axten et al., 2013]); 500 mM SP600125 (for GCN2 inhibition; Calbiochem [Robert
et al., 2009]); 500 mM indirubin-30-monoxime (for GCN2 inhibition; Calbiochem [Robert et al., 2009]); 100 mM imidazole-oxindole C16
(for PKR inhibition; Sigma-Aldrich [Jammi et al., 2003]); and 50 mM hemin (for HRI inhibition; Sigma-Aldrich [Fagard and London,
1981]) before flow cytometric analysis. Cycloheximide was used at 50 mM concentrations. Autophagy Blue was used according
to manufacturer’s instructions (Sigma-Aldrich).
Bromodeoxyuridine Experiments
Mice were fed with 2 mg/mL BrdU in the drinking water for the durations indicated. Animals were injected with 100 mg 2NBDG intra-
venously and euthanized 15 min later. Because formaldehyde ablates 2NBDG fluorescence (data not shown), plasma cell subsets
were purified by fluorescence activated cell sorting prior to fixation, permeabilization, and intracellular analysis of BrdU incorporation
and retention. Splenic plasma cells, memory B cells and CD138-enriched bone marrow plasma cells were first stained for surface
expression of respective antibodies. Cells were then purified by Fluorescence-activated cell sorting and then fixed, permeabilized,
and stained for incorporated BrdU with the FITC BrdU Flow kit (BD Biosciences) according to the manufacturer’s instructions.
2NBDG does not survive fixation, allowing for the use of fluorescein derivative-conjugated antibodies for intracellular analysis after
cells were purified by FACS.
Immunizations
Mice were immunized intraperitoneally with 100 mg NP-Ova (Biosearch), adjuvanted with Alhydrogel (Invivogen). NP-APC used
for staining was made by conjugating allophycocyanin (Sigma-Aldrich) with 4-hydroxy-3-nitrophenylacetyl-O-succinimide ester
(Biosearch Technologies).
ELISAs
Supernatant collected was serially diluted 1:4, 1:16, 1:64 in antibody buffer (PBS + 2% BSA + 0.05% Tween). Standard curves were
made with unlabeled mouse IgG (Southern Biotech) to 100, 20, 4, 0.8, 0.16, and 0.032 ng/ml. Ninety-six well high binding plates
(Corning) were coated with purified rat a-mouse Ig kappa, light chain (BD Pharmingen) at 5 mg/mL in ELISA coating buffer (0.1M
bicarbonate, pH 9.5) overnight at 4C. Plates were washed four times with PBS + 0.05% Tween before blocking for one hour with
PBS + 2% BSA. Blocking buffer was flicked out and samples were plated for one hour at room temperature. Plates were washed
four times with PBS + 0.05% Tween. Plates were coated with 0.13 mg/mL Biotin-SP-conjugated AffiniPure Donkey Anti-Mouse
IgG (H+L) (Jackson Immunoresearch) in antibody buffer and incubated for one hour at room temperature. This secondary antibody
recognizes all isotypes due to light chain reactivity. Plates were then washed four times with PBS + 0.05% Tween. Wells were incu-
bated with 1:1000 streptavidin HRP (BD Pharmingen) in antibody buffer for one hour at room temperature. After incubation, wells
were washed 33with PBS + 0.05%Tween and 33with PBS followed by development with 100 mL of 3,30,5,50- Tetramethulbenzidine
dihydrochloride hydrate (TMB) (Dako) and quenched with 2N H2SO4. ELISA absorbance values were analyzed at 450 nm. Antibody
titers were calculated using standard curves generated with known mouse IgG concentrations.
Flow Cytometry/Sorting
All fluorescence activated cell sorting was performed on a BD FACS Aria II. Cells were sorted into phosphate-buffered saline con-
taining 5% bovine serum. All flow cytometric analysis was performed on a BD FACS Aria II, LSR II, or LSR Fortessa. Data was
analyzed using FlowJo software (FlowJo Enterprise). The following a-mouse antigen antibodies were used in this study: CD138-
phycoerythrin (PE) (281-2; Biolegend); B220-allophycocyanin (APC)-Cy7 (RA3-6B2; Biolegend); CD93-PE-Cy7 (AA4.1; Biolegend);
p-S6-V450 (N7-548, BD Biosciences); p-eIF2a-Alexa 647 (E90; Abcam); Igk-PE-Cy7 (187.1, BD Biosciences); CD45.2-BV510
(104: Biolegend); CD45.1-BV605 (A20; Biolegend). For intracellular stains of p-S6 and p-eIF2a, plasma cell subsets were first
purified by FACS, fixed with 2% paraformaldehyde (Electron Microscopy Services), and permeabilized with cold 100% methanol
prior to staining. For intracellular stains of Igk, cells were fixed with 2% paraformaldehyde and permeabilized with 0.1% saponin
(Sigma-Aldrich) prior to staining.
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qRT-PCR
Total RNAwas prepared fromdouble-sorted bonemarrowplasma cell (20,000-60,000) and four different splenic plasma cell (10,000–
100,000) populations using NucleoSpin RNA isolation kit (Macherey-Nagel) and first strand cDNA synthesis was performed with
Superscript III Reverse transcription kit using oligo (dT) primers or random hexamers (Life Technologies) according to the manufac-
turer’s instructions. qRT-PCRwas performed using SYBRGreen PCRmaster mix (Applied Biosystems) on a StepOnePlus Real-Time
PCR system (Applied Biosystems). The primer sequences, reported previously (Oslowski and Urano, 2011), are as follows: XBP1s,
50-CTGAGTCCGAATCAGGTGCAG-30 (forward) and 50-GTCCATGGGAAGATGTTCTGG-30 (reverse); XBP1, 50- TGGCCGGGTC
TGCTGAGTCCG (forward) and 50-GTCCATGGGAAGATGTTCTG-30 (reverse); HSPA5, 50-TTCAGCCAATTATCAGCAAACTCT-30
(forward) and 50-TTTTCTGATGTATCCTCTTCACCAGT-30 (reverse); DDIT3, 50-CATACACCACCACACCTGAAAG-30 (forward) and
50- CCGTTTCCTAGTTCTTCCTTGC30 (reverse); EDEM1, 50-CCTCAATGTGGCCAGAACTT-30 (forward) and 50- CAGGACCTTTG
CACAGGAAT-30 (reverse); PERK, 50- GAAATCTCTGACTACATACGGAC-30 (reverse) and 50-ACACTGAAATTCCACTTCTCAC-30
(forward); HPRT, 50-TTATGGACAGGACTGAAAGAC-30 (forward) and 50- GCTTTAATGTAATCCAGCAGGT30 (reverse). Expression
of each ER stress gene was normalized to HPRT.
Electron Microscopy
Transmission electron microscopy of mouse splenic plasma cell subsets was performed by the Molecular Microbiology Imaging Fa-
cility at Washington University. For ultrastructural analysis, 3–5 3 104 sorted cells were fixed in 2% paraformaldehyde/2.5% glutar-
aldehyde (Ted Pella, Redding, CA, USA) in 100 mM cacodylate buffer (pH 7.2) for 1 hr at room temperature. Samples were washed in
cacodylate buffer and postfixed in 1% osmium tetroxide (Polysciences, Warrington, PA, USA) for 1 hr. Samples were then rinsed
extensively in dH20 prior to en bloc staining with 1% aqueous uranyl acetate (Ted Pella) for 1 hr. Following several rinses in dH20,
samples were dehydrated in a graded series of ethanol and embedded in Eponate 12 resin (Ted Pella). Sections of 95 nm were
cut with a Leica Ultracut UCT7 ultramicrotome (Leica Microsystems, Bannockburn, IL, USA), stained with uranyl acetate and lead
citrate, and viewed on a JEOL 1200 EX transmission electron microscope (JEOL USA, Peabody, MA, USA) equipped with an
AMT 8 megapixel digital camera and AMT Image Capture Engine V602 software (Advanced Microscopy Techniques, Woburn,
MA, USA). ER lumenal width analysis was performed using ImageJ software, and scored blinded to the cellular subset.
In Vivo Ribopuromycylation
Wild-type IgHa mice were injected with 1 mg of puromycin (EMD Millipore) intraperitoneally and euthanized 15 min later. Following
fixation and permeabilization as previously described (Seedhom et al., 2016), puromycin incorporation was detected using a mono-
clonal antibody (clone 2A4 from the Developmental Studies Hybridoma Bank at the University of Iowa) followed by a biotin mouse
anti-mouse IgG2a[b] (clone: 5.7 from BD Pharmingen) and finally BV605 streptavidin (BD Horizon).
CaspGLOW Assay
Caspase 12 activation was measured using the CaspGLOW staining kit (Biovision). Sorted cells were spun down and cultured in
custom physiological media supplemented with 1% Pen/Strep, 5 mM glucose, 500 mM glutamine, and 10% FBS and 1 mL of
FITC-ATAD-FMK (from kit) for 1 hr in hypoxic conditions (5% O2, 5% CO2, 37C). Cells were analyzed by flow cytometry and
FITC-positive cells indicate active caspase-12.
Immunoglobulin Repertoire Analysis
For these analyses, we sorted all recoverable plasma cells from spleen and bone marrow of femurs, tibiae, humerus, and pelvis
bones, generating approximately 30,000 cells of each subset. Sorted cells were lysed and RNA made using the NucleoSpin RNA
XS kit (Macherey-Nagel) per manufacturer’s instruction. cDNA was generated using Superscript III First-Strand Synthesis System
for FT (Thermo Fisher) with oligo dT per manufacturer’s instructions. PCR primers as previously reported were modified for MiSeq
analysis as described below (Menzel et al., 2014; Tiller et al., 2009). IgM immunoglobulin transcripts were amplified with first round
PCR with the following primers: msVHEstdseq1 50-TCTTTCCCTACACGATCTGGGAATTCGAGGTGCAGCTGCAGGAGTCTGG-30
and common mu stdseq2 50-GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTAGGGGGAAGACATTTGGGAAGGAC-30. PCR
products were cleaned using gel/PCR DNA fragments extraction kit (IBI Scientific). PCR products were then used as templates
for a second round of amplification with the following primers: P5 forward Stdseq 50-AATGATACGGCGACCACCGAGATCTACAC
TCTTTCCCTACACGACGC-30 and P7 reverse Stdseq index 50CAAGCAGAAGACGGCATACGAGATNNNNNNNNGTGACTGGAG
TTCAGACGTGTGTG-30 where N represents a unique combination for barcoding purposes. For IgG repertoire analysis, cDNA
was first amplified using the following primers: msVHEstdseq1 50-TCTTTCCCTACACGATCTGGGAATTCGAGGTGCAGCTGCAG
GAGTCTGG-30 and a combination of
Cg1 primer 50- GGAAGGTGTGCACCGCTGGAC-30,
Cg2c primer 50-GGAAGGTGCACACTGGAC-30,
Cg2b primer 50- GGAAGGTGCACACTGCTGGAC-30,
Cg3 primer 50-AGACTGTGCGCACACCGCTGGAC-30.
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This was followed by a second round of PCR with: msVHEstdseq1 50-TCTTTCCCTACACGATCTGGGAATTCGAGGTGCAGCTG
CAGGAGTCTGG-30 and a common Cg primer: 50- GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTCAAGGTGGATAGAGAG
CATCGATGGGG-30. This was followed by a final amplification cycle with P5 forward Stdseq and P7 reverse Stdseq index. Samples
were then pooled, gel purified, and then sequenced using the Illumina Miseq 2 3 250 platform with the following primers: Stdseq1:
50-ACACTCTTTCCCTACACGACGCTCTTCCGATCT-30; Stdseq2: 50-GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCT-30; and
Index seq: 50-GATCGGAAGAGCACACGTCTGAACTCCAGTCAC-30. Repertoire information was extracted from fastq files using
Mixcr (Bolotin et al., 2015) and displayed using Clonoplot (Fa¨hnrich et al., 2017). Approximately 150,000 reads were obtained for
each sample, which when corrected for isotype usage corresponds to 7–153 coverage. Given that none of the subsets displayed
more than 4,000 distinct CDR3 regions, the data approach sequencing saturation.
RNA-Seq
RNA was prepared from approximately 30,000 plasma cells as described above. Human plasma cell RNA-seq data were obtained
from our previous studies (Jash et al., 2016; Lam et al., 2016). Sequencing libraries were generated using a Clontech Smart-Seq kit
and Nextera DNA library prep kit (Illumina). Single end 50bp reads were acquired using an Illumina HiSeq 2500. Reads were mapped
using Salmon (Patro et al., 2017), and differential gene expression analysis was performed using DESeq2 (Love et al., 2014). Refer-
ence transcriptomes and annotation files that include immunoglobulin variable and constant region geneswere downloaded from the
Gencode Project: (ftp://ftp.sanger.ac.uk/pub/gencode/Gencode_mouse/release_M16/gencode.vM16.pc_transcripts.fa.gz). Inter-
section analysis was performed using Microsoft Access, and Venn Diagrams were generated using https://www.meta-chart.com/
venn#/data. Heatmaps were generated using http://www.heatmapper.ca/.
Single-Cell RNA-Seq
Approximately 5000 LY6G- CD11c- plasma cells of each subset were double-sorted and prepared for RNA-sequencing using a
Chromium Single Cell 30 Library & Gel Bead Kit and a Single Cell Controller from 10x Genomics according to manufacturer’s instruc-
tions. Sequencing libraries were prepared using Illumina Nextera kits, and each sample was sequenced in its own Illumina HiSeq
2500 lane. Sequencing files were aggregated, normalized, and processed using the Cell Ranger program (10x Genomics) and visu-
alized using Loupe Browser (10x Genomics). Minimum read cutoffs to focus the analysis on high-quality single cells were left at
default settings. Clusters were automatically defined by a graph-based method. Immunoglobulin isotypes and subset-specific
expression of neutrophil degranulation genes were visualized using SeqGeq (FlowJo).
13C Tracing Experiments
Human bone marrow plasma cells were purified using CD138 beads as previously described (Lam et al., 2016). Approximately 2 3
106 cells were cultured in 2ml of physiological media containing either 5mM uniformly labeled 13C glucose or 500 mM uniformly
labeled glutamine for 24 hours. Cells were harvested and extracted as previously described (Yao et al., 2016). Samples were sepa-
rated on a Luna aminopropyl column (3 mm, 150mm3 1.0 mm I.D., Phenomenex) coupled to an Agilent 1260 capillary HPLC system.
The Luna column was used in negative mode with the following buffers and linear gradient: A = 95% water, 5% acetonitrile (ACN),
10 mM ammonium hydroxide, 10 mM ammonium acetate; B = 95% ACN, 5% water; 100% to 0% B from 0-45 min and 0% B from
45-50min; flow rate 50 mL/min.Mass spectrometry detection was carried out on an Agilent 6540Q-TOF coupledwith ESI source. The
identity of each metabolite was confirmed by comparing retention times and tandem MS data with standard compounds. The iso-
topologue distributions were corrected for natural abundance and isotope impurity.
QUANTIFICATION AND STATISTICAL ANALYSIS
Student’s t tests, 1-way ANOVAs with post hoc Tukey’s multiple comparison tests, and 2-way ANOVAs with post hoc Sidak’s mul-
tiple comparison tests were performed using Prism software (Graphpad). Figure legends specify the test used, criteria for statistical
significance, and experimental replicates. Figures and/or legends specify the number of technical and biological replicates per
experiment. Adjusted p values and fold changes for RNA-seq were calculated using DESeq2 (Love et al., 2014). Significant genes
in single cell RNA-seq experiments were identified using Loupe Browser, which applied a Benjamini-Hochberg correction for multiple
comparisons to generate adjusted p values.
DATA AND SOFTWARE AVAILABILITY
The accession number for the RNA-seq data reported in this paper is NCBI GEO: GSE115860.
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